A Pilot Trial of Enoxaparin Versus Aspirin in Patients With Cancer and Stroke

Trial Profile

A Pilot Trial of Enoxaparin Versus Aspirin in Patients With Cancer and Stroke

Active, no longer recruiting
Phase of Trial: Phase I/II

Latest Information Update: 10 Oct 2016

At a glance

  • Drugs Enoxaparin sodium (Primary) ; Aspirin
  • Indications Embolism and thrombosis; Stroke
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 06 Oct 2016 Status changed from recruiting to active, no longer recruiting.
    • 08 Apr 2016 Planned End Date changed from 1 Dec 2017 to 1 Dec 2018 as reported by ClinicalTrials.gov record.
    • 08 Apr 2016 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2018 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top